Cipla partner Stempeutics gets DCGI nod for stem cell-based product

Cipla – Stempeutics tie up | DCGI grants limited approval for manufacturing and marketing of Stempeucel-First of kind product in India-for the treatment of Critical Limb Ischemia due to Buerger’s Disease.Watch Full Movie Streaming Online and Download

Drugs<>Therapeutics<>Big Pharma
impas Natesh Prabhu Administrator & Chief Editor | Clinical Pharmacologist | Diabetic-Sexual Medicine-Regenerative Therapy Consultant | President, Indian Medical Pharmacologists Association